Found 12 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Cytochrome P450 2C8
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C8 in human liver microsomes measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C8
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C8 in human liver microsomes measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2CJ in human liver microsomes measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP1A2 in human liver microsomes measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2CJ in human liver microsomes measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 in human liver microsomes measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2D6 in human liver microsomes measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2D6 in human liver microsomes measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 in human liver microsomes measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D4
(Rattus norvegicus) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of rat CYP2D4 measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of CYP1A2 in human liver microsomes measured after concurrent incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D4
(Rattus norvegicus) | BDBM50444436
(CHEMBL3092124)Show SMILES Cc1cc2c(c(C(O)=O)n(Cc3cc4ccccc4nc3Cl)c2cc1F)-c1ccc[nH]c1=O |(42.83,-22,;44.16,-22.77,;45.49,-22,;46.83,-22.76,;48.3,-22.27,;49.22,-23.52,;50.76,-23.51,;51.52,-22.17,;51.54,-24.84,;48.31,-24.78,;49.09,-26.11,;48.34,-27.45,;46.8,-27.46,;46.05,-28.8,;44.51,-28.81,;43.75,-30.15,;44.54,-31.48,;46.07,-31.46,;46.82,-30.12,;48.37,-30.11,;49.12,-28.77,;50.66,-28.74,;46.83,-24.31,;45.49,-25.08,;44.16,-24.31,;42.82,-25.08,;48.3,-20.74,;46.98,-19.97,;46.97,-18.43,;48.31,-17.66,;49.65,-18.44,;49.64,-19.97,;50.97,-20.75,)| Show InChI InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
PDB
UniChem
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of rat CYP2D4 measured after compound pre-incubation |
Bioorg Med Chem Lett 23: 6585-7 (2013)
Article DOI: 10.1016/j.bmcl.2013.10.060
BindingDB Entry DOI: 10.7270/Q2GF0W06 |
More data for this
Ligand-Target Pair | |
Search and Browse
